USP <665> goes live in 2026. Are your polymer components compliant? Learn why early risk assessment is the key—and how to prepare.
ICH M14 provides a global framework for non‑interventional studies using real‑world data, enhancing transparency, consistency, and methodological.
ICH E6(R3) Annex 2 draft reshapes GCP for decentralized and real-world data–driven trials.
FDA QMSR: practical answers to the most common industry questions.
The FDA QMSR Final Rule aligns 21 CFR 820 with ISO 13485:2016. Learn what changes and how medical device manufacturers should prepare.
The transition to IVDR introduces new challenges for IVD manufacturers, with stricter requirements and revised timelines to ensure compliance
Medicines in Europe need Marketing Authorization and ongoing safety monitoring to ensure compliance and patient safety.
New ICH Q2 (R2) and ICH Q14 set to revolutionize analytical method validation in the pharmaceutical industry, enhancing quality, safety, and.
Learn about the importance of clinical and pre-clinical trials for veterinary medicinal products, including regulatory requirements, study types, and.
From streamlining processes to enhancing data analytics, learn how embracing digital technologies revolutionizes industry operations.
